Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.41 EUR | -41.01% | -.--% | -14.58% |
2023 | Traumhaus AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2023 | Traumhaus AG Provides Sales Guidance for the Year 2023 | CI |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.42 for the 2023 fiscal year.
- The company appears to be poorly valued given its net asset value.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Sales forecast by analysts have been recently revised upwards.
- For the past twelve months, EPS forecast has been revised upwards.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- One of the major weak points of the company is its financial situation.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- TRU Stock
- Ratings Traumhaus AG